<HashMap><database>MetabolomicsWorkbench</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>http://www.metabolomicsworkbench.org/rest/study/study_id/ST000791/mwtab</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><technology_type>Mass Spectrometry</technology_type><technology_type>ESI</technology_type><disease>Cancer</disease><full_dataset_link>http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&amp;StudyID=ST000791</full_dataset_link><study_factor>Grouping:Slow Progress</study_factor><study_factor>Grouping:Quick Progress</study_factor><tissue>Bone Marrow</tissue><sample_protocol>Reversed phase POSITIVE ION MODE.</sample_protocol><repository>MetabolomicsWorkbench</repository><data_protocol></data_protocol><omics_type>Metabolomics</omics_type><species>Homo Sapiens</species><submitter_affiliation>Mayo Clinic</submitter_affiliation><metabolite_name>Taurine</metabolite_name><metabolite_name>alpha-Amino-N-butyric-acid</metabolite_name><metabolite_name>Serine</metabolite_name><metabolite_name>Hydroxyproline</metabolite_name><metabolite_name>Proline</metabolite_name><metabolite_name>Carnosine</metabolite_name><metabolite_name>Leucine</metabolite_name><metabolite_name>Aspartic Acid</metabolite_name><metabolite_name>1-Methylhistidine</metabolite_name><metabolite_name>Glycine</metabolite_name><metabolite_name>Cystine</metabolite_name><metabolite_name>Cystathionine 1</metabolite_name><metabolite_name>Phosphoethanolamine</metabolite_name><metabolite_name>Histidine</metabolite_name><metabolite_name>allo-Isoleucine</metabolite_name><metabolite_name>Arginine</metabolite_name><metabolite_name>Anserine</metabolite_name><metabolite_name>beta-Alanine</metabolite_name><metabolite_name>3-Methylhistidine</metabolite_name><metabolite_name>Isoleucine</metabolite_name><metabolite_name>Cystathionine 2</metabolite_name><metabolite_name>Tyrosine</metabolite_name><metabolite_name>beta-Aminoisobutyric-acid</metabolite_name><metabolite_name>Ethanolamine</metabolite_name><metabolite_name>Alanine</metabolite_name><metabolite_name>gamma-Amino-N-butyric-acid</metabolite_name><metabolite_name>Phenylalanine</metabolite_name><metabolite_name>Threonine</metabolite_name><metabolite_name>Methionine</metabolite_name><metabolite_name>Tryptophan</metabolite_name><metabolite_name>Citrulline</metabolite_name><metabolite_name>Hydroxylysine 1</metabolite_name><metabolite_name>Glutamic Acid</metabolite_name><metabolite_name>Hydroxylysine 2</metabolite_name><metabolite_name>Lysine</metabolite_name><metabolite_name>Valine</metabolite_name><metabolite_name>Sarcosine</metabolite_name><metabolite_name>alpha-Aminoadipic-acid</metabolite_name><metabolite_name>Asparagine</metabolite_name><metabolite_name>Ornithine</metabolite_name><metabolite_name>Homocystine</metabolite_name><metabolite_name>Glutamine</metabolite_name><name_synonyms>Plasma-Cell Myelomas, Plasma-cell myeloma, Fresh, Disease, Frozen Plasma, Myelomas, Fresh Frozen Plasma, Myeloma, Multiple myeloma (disorder), Kahler's disease, Aminokarbonsaeure, Blood, Aminosaeure, Cell Myelomas, Aminocarbonsaeure, Amino acid, Myeloma Multiple, alpha-amino acids, alpha-amino acid, Myeloma-Multiples, Plasmas, Myeloma-Multiple, Cell, alpha-amino carboxylic acids, Multiple Myeloma, MM, Al amyloidosis, multiple myeloma, Frozen Plasmas, Kahler, Multiple Myelomas, medulla ossium, Marrow, medulla ossea, [M]Plasma cell myeloma, Myelomatoses, NOS, Myelomatosis, Yellow, MULT MYELM W/O REMISSION, morphology (morphologic abnormality), Plasma-Cell, Plasma-Cell Myeloma, plasma., Plasmacytic myeloma, systemic, Plasma, Amino Acid, Acid, amyloidosis, Yellow Marrow, Fresh Frozen Plasmas, Fresh Frozen, Blood Plasma, Multiple myeloma, amino acids, Amino acids, medullary bone, medulla of bone, Plasma Cell Myelomas, myeloma, Kahler Disease, portion of plasma, Amino, Multiple myeloma without mention of remission, Red Marrow, Multiple, no ICD-O subtype, Cell Myeloma, multiple, Plasma Cell Myeloma, no ICD-O subtype (morphologic abnormality), Blood Plasmas, Red, Acids, Multiple myeloma (clinical), Plasma Cell, Bone, myeloma - multiple</name_synonyms><sample_synonyms>backward, reversed.</sample_synonyms></additional><is_claimable>false</is_claimable><name>Identifying metabolic adaptations characteristic of multiple myeloma cells via amino acids concentrations from bone marrow plasma</name><description/><dates><publication></publication></dates><accession>ST000791</accession><cross_references><TAXONOMY>9606</TAXONOMY></cross_references></HashMap>